AstraZeneca’s $1 Billion Acquisition of EsoBiotec

Leila Ahmed Europe Legal Chronicle
Tagged:

Covington & Burling advised AstraZeneca on the deal. AstraZeneca (LSE/STO/Nasdaq: AZN) announced its definitive agreement to acquire EsoBiotec SA, a biotechnology company pioneering in vivo cell…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here